On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


SenesTech Inc. (NASDAQ: SNES) Continues to Increase Rat Birth Control Product Distribution Through Agreement with Poppe Enterprises

  • Arizona-based SenesTech has developed a portfolio of rodent birth control products as a very effective alternative to deadly poisons often used to control rat populations
  • SenesTech’s most recent product rollout is a soft bait formulation of its Birth Control for Rats(TM) branded Evolve(TM), in response to pest management businesses that prefer solid baits to SenesTech’s initial liquid products
  • The company recently announced a partner agreement with grain management market distributor Poppe Enterprises to stock Evolve(TM) at outlets in states from North Dakota to Kansas and Colorado, following on the heels of a similar agricultural distribution agreement with a global irrigation solutions company

From New Orleans (https://ibn.fm/MyxuC) to Michigan (https://ibn.fm/nBfPB), eastward to Massachusetts (https://ibn.fm/1sMU1), and across the Atlantic to Europe (https://ibn.fm/6lMiL), concerns about confronting rats in the world’s cities continue to occupy news reports. But rats cause even more damage in agriculture.

Rodent pest control enterprise SenesTech (NASDAQ: SNES) is based in Arizona has begun to establish a global reach for its innovative Birth Control for Rats(TM) products, and the company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on food markets.

On Jan. 29, SenesTech announced the signing of a distribution agreement with Poppe Enterprises LLC for the grain management market. Poppe Enterprises will be a stocking distributor for SenesTech’s Evolve(TM) soft bait in the outlets it serves in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado, according to the announcement.

“We are partnering with a leader and innovator in grain management and pest control,” SenesTech President and CEO Joel Fruendt stated (https://ibn.fm/K4hrs). “Poppe Enterprises has a keen focus on innovation, safety, and sustainability, and a strong reputation in this substantial market. Their presence and market knowledge will mean immediate penetration of the Evolve product.”

SenesTech’s Evolve(TM) soft bait delivers a cottonseed oil formulation that inhibits fertility in both male and female rats, using a highly palatable and effective alternative to deadly poisons. While Evolve(TM) can also work in concert with poisons to stop rodents from breeding and then to eliminate the rodents altogether, poisons can’t be broadcast in agricultural settings and the use of traps has limited effectiveness.

SenesTech’s agreement with Poppe Enterprises follows close on the heels of its agreement with a global sustainable irrigation solutions company to introduce Evolve(TM) to a California dairy and almond growing customer, with an eventual expansion goal to other customers around the world (https://ibn.fm/RMAhh).

Evolve(TM) is the latest entry into SenesTech’s portfolio of rat fertility control products. The company’s liquid bait formulation ContraPest(R) was the first rat contraceptive registered with the U.S. Environmental Protection Agency (“EPA”) that affects both male and female rats, and the company remains unchallenged in that regard.

The introduction of Evolve(TM) in October marked a new era for the company in response to pest management businesses that prefer solid baits they’re already equipped to use, as opposed to liquid formulations that are used far less often.

Market analysts at Straits Research valued the global rodent control market size at $2.86 billion in 2022 with an anticipated CAGR of 6.19 percent between 2023 and 2031, when it is expected to reach $4.9 billion (https://ibn.fm/3tkW2). MarketsandMarkets analysts valued their estimates at $5.4 billion in 2022, with an expected CAGR of 5.8 percent through 2027 lifting the market to a $7.1 billion valuation by that year (https://ibn.fm/39cX6).

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

From Our Blog

Fast-Tracking a Capital Raise in the Public Markets

April 19, 2024

The SPAC Conference 2024 Hosted by DealFlow Events Successful people know when facing a business challenge their best weapon is information. Anyone involved in any way with special purpose acquisition companies cannot afford to miss The SPAC Conference 2024 coming up fast. This best-in-class event set for June 11-12 delivers the vital information and insight […]

Rotate your device 90° to view site.